Aplindore

DRUG2 trials

Sponsors

Ligand Pharmaceuticals

Conditions

Early Stage Parkinson's DiseaseRestless Legs Syndrome

Phase 2

The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease

CompletedNCT00623324

Ligand PharmaceuticalsEarly Stage Parkinson's Disease

Start: 2008-01-31Target: 40Updated: 2011-10-03

The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome

CompletedNCT00626418

Ligand PharmaceuticalsRestless Legs Syndrome

Start: 2008-02-29Target: 24Updated: 2011-10-03